Literature DB >> 9716028

The biochemical modification of the erythrocyte membranes from women with ovarian cancer.

Z Kopczyński1, J Kuźniak, A Thielemann, J Kaczmarek, M Rybczyńska.   

Abstract

The aim of our work was quantitative evaluation of the protein and phospholipid fractions of mature erythrocyte membranes separated from women with ovarian cancer. Blood was sampled from 30 women with ovarian cancer, aged 24-79 years, in the third stage of clinical progression of the disease. Phospholipids were separated from membranes by Müller's acidic extraction method and analysed in thin-layer two-dimensional chromatography. On the silica gel plates nine fractions of phospholipids were separated: sphingomyelin (SPH), phosphatidylethanolamine (PE), phosphatidlyserine (PS), phosphatidylcholine (PC), lysophosphatidylcholine (LPC), phosphatidic acid (PA), phosphatidylinositol (Ptd Ins), phosphatidylinositol-4-phosphate (Ptd Ins-4-P), phosphatidylinositol-4,5-diphosphate (Ptd Ins-4,5-P2). The activity of phospholipase C in erythrocyte membranes was determined by Akhrem's spectrophotometric method. Membrane proteins were separated by polyacrylamide gel electrophoresis, SDS-PAGE. It was shown that PS, SPH, LPC and PA fractions were significantly diminished. The concentration of Ptd Ins-4-P and Ptd Ins-4,5-P2 was significantly increased with simultaneous reduction in Ptd Ins level. The inhibition of phospholipase C reached 80%. The quantitative protein evaluation showed a statistically significant decrease in spectrin and a significant increase in 4.1 protein. The quantitative changes, observed in phospholipid and protein fractions, led to the restructuring of the erythrocyte membrane cytoskeleton, which may be connected to increased susceptibility to haemolysis of red blood cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9716028      PMCID: PMC2063097          DOI: 10.1038/bjc.1998.516

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  37 in total

1.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

2.  Visualization of the protein associations in the erythrocyte membrane skeleton.

Authors:  T J Byers; D Branton
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

3.  Quantitative two-dimensional thin-layer chromatography of blood phospholipids.

Authors:  R M Broekhuyse
Journal:  Clin Chim Acta       Date:  1969-03       Impact factor: 3.786

4.  Interaction of cytoskeletal proteins on the human erythrocyte membrane.

Authors:  D Branton; C M Cohen; J Tyler
Journal:  Cell       Date:  1981-04       Impact factor: 41.582

5.  Abnormalities in membrane phospholipid organization in sickled erythrocytes.

Authors:  B Lubin; D Chiu; J Bastacky; B Roelofsen; L L Van Deenen
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

6.  Phosphoinositide metabolism and the morphology of human erythrocytes.

Authors:  J E Ferrell; W H Huestis
Journal:  J Cell Biol       Date:  1984-06       Impact factor: 10.539

7.  A structural model of human erythrocyte protein 4.1.

Authors:  T L Leto; V T Marchesi
Journal:  J Biol Chem       Date:  1984-04-10       Impact factor: 5.157

8.  Huntington disease and Tourette syndrome. I. Electron spin resonance of bed ghosts.

Authors:  D E Comings; A Pekkala; J R Schuh; P C Kuo; S I Chan
Journal:  Am J Hum Genet       Date:  1981-03       Impact factor: 11.025

9.  Spectrin as a stabilizer of the phospholipid asymmetry in the human erythrocyte membrane.

Authors:  C W Haest; G Plasa; D Kamp; B Deuticke
Journal:  Biochim Biophys Acta       Date:  1978-05-04

Review 10.  Plasma membrane phospholipid organization in human erythrocytes.

Authors:  R S Schwartz; D T Chiu; B Lubin
Journal:  Curr Top Hematol       Date:  1985
View more
  1 in total

1.  Paraneoplastic autoimmune hemolytic anemia in ovarian cancer: a marker of disease activity.

Authors:  Kah Poh Loh; Ankit Kansagra; Armen Asik; Syed Ali; Saurabh Dahiya
Journal:  Rare Tumors       Date:  2015-02-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.